Esperion Therapeutics
ESPR
#6734
Rank
NZ$0.83 B
Marketcap
$4.23
Share price
2.49%
Change (1 day)
115.10%
Change (1 year)

Esperion Therapeutics (ESPR) - Cash on Hand

Cash on Hand as of June 2024 : NZ$0.32 Billion

According to Esperion Therapeutics's latest financial reports the company has NZ$0.32 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Esperion Therapeutics - Cash on Hand chart (from 2000 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31NZ$0.13 B-50.51%
2022-12-31NZ$0.26 B-30.78%
2021-12-31NZ$0.37 B-10.17%
2020-12-31NZ$0.42 B41.77%
2019-12-31NZ$0.29 B47.02%
2018-12-31NZ$0.20 B-28.06%
2017-12-31NZ$0.28 B-7.71%
2016-12-31NZ$0.30 B-1.51%
2015-12-31NZ$0.31 B129.58%
2014-12-31NZ$0.13 B84.82%
2013-12-31NZ$73.08 M823.38%
2012-12-31NZ$7.91 M293.21%
2011-12-31NZ$2.01 M
2002-12-31NZ$85.7 M-49.37%
2001-12-31NZ$0.16 B6.81%
2000-12-31NZ$0.15 B1302.75%
1999-12-31NZ$11.29 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NZ$1.30 B 303.49%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.59 B 391.51%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$17.03 B 5,157.15%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$16.76 B 5,075.01%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.42 B 31.93%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.53 B 63.74%๐Ÿ‡บ๐Ÿ‡ธ USA